Global DNA Probe-based Diagnostic Market 2017-2021

DNAプローブベース診断の世界市場2017-2021

◆タイトル:Global DNA Probe-based Diagnostic Market 2017-2021
◆商品コード:IRTNTR15308
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2017年11月15日
◆ページ数:85
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

Technavio社が発行した当調査レポートでは、DNAプローブベース診断の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、DNAプローブベース診断の世界市場規模及び予測、用途別分析、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。Technavio社はDNAプローブベース診断の世界市場が2017-2021年期間中に年平均10.95%成長すると予測しています。当レポート上に記載されている主な企業は、Abbott Laboratories、F. Hoffmann La Roche、GE Healthcare、Thermo Fisher Scientific等です。

About DNA Probe-based Diagnostic
The DNA probe is a basic component in most molecular diagnostic techniques. The DNA probe is a labeled DNA strand synthesized in the laboratory. Its purpose is to hybridize with the target nucleic acid molecule to be identified from a biological sample. A probe is composed of a strand of 30-40 nucleotides called oligonucleotides. These oligonucleotides are labeled with a detector molecule. When hybridization occurs between the probe and the target organism’s nucleic acid, the hybrid can be detected through the detector molecule.

Technavio’s analysts forecast the global DNA probe-based diagnostic market to grow at a CAGR of 10.95% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global DNA probe-based diagnostic market for 2017-2021. To calculate the market size, the report considers the revenue generated from the retail sale of DNA probe-based diagnostic products.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global DNA Probe-based Diagnostic Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Abbott Laboratories
• F. Hoffmann La Roche
• GE Healthcare
• Thermo Fisher Scientific

[Other prominent vendors]
• BD
• Biogenex
• bioMerieux
• Biolegio
• Luminex
• MP Biomedicals

[Market driver]
• Growing incidence and prevalence of cancer
• For a full, detailed list, view our report

[Market challenge]
• Highly complex technique
• For a full, detailed list, view our report

[Market trend]
• Advancement in DNA array
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

Table of Contents
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: INTRODUCTION
• Market outline

PART 05: MARKET LANDSCAPE
• Market size and forecast
• Five forces analysis

PART 06: MARKET SEGMENTATION BY APPLICATION
• Global DNA probe-based diagnostics market by application
• Global DNA probe-based diagnostics market by infectious disease testing
• Global DNA probe-based diagnostics market by cancer testing
• Global DNA probe-based diagnostics market by others

PART 07: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• DNA probe-based diagnostics market in Americas
• DNA probe-based diagnostics market in EMEA
• DNA probe-based diagnostics market in APAC
• Market opportunity

PART 08: DECISION FRAMEWORK

PART 09: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges

PART 10: MARKET TRENDS
• Advancement in DNA array
• Increase in molecular research activities
• Increasing importance of promotional activities
• Increasing prominence of DNA probe technology in diagnosing vaginitis

PART 11: VENDOR LANDSCAPE
• Competitive scenario
• Investment opportunity

PART 12: KEY VENDOR ANALYSIS
• Abbott Laboratories
• F. Hoffmann La Roche
• GE Healthcare
• Thermo Fisher Scientific
• Other prominent vendors

PART 13: APPENDIX
• List of abbreviations

[List of Exhibits]
Exhibit 01: Primary types of DNA probe assays used for diagnosis
Exhibit 02: Several diagnostic areas depending on DNA probe-based technology
Exhibit 03: Global DNA probe-based diagnostics market: Market overview
Exhibit 04: Global DNA probe-based diagnostics market 2016-2021 ($ billions)
Exhibit 05: Factors impacting the global DNA probe-based diagnostics market
Exhibit 06: Five forces analysis
Exhibit 07: Global DNA probe-based diagnostics market by application 2016-2021 (% share)
Exhibit 08: Global DNA probe-based diagnostics market by infectious disease testing 2016-2021 ($ billions)
Exhibit 09: Global DNA probe-based diagnostics market by cancer testing 2016-2021 ($ billions)
Exhibit 10: Global DNA probe-based diagnostics market by others 2016-2021 ($ billions)
Exhibit 11: Geographical segmentation 2016-2021– Market share
Exhibit 12: Regional comparison
Exhibit 13: DNA probe-based diagnostics market in Americas 2016-2021 ($ billions)
Exhibit 14: DNA probe-based diagnostics market in Americas: Year-over-year growth
Exhibit 15: Top 3 countries in Americas
Exhibit 16: DNA probe-based diagnostics market in EMEA 2016-2021 ($ billions)
Exhibit 17: DNA probe-based diagnostics market in EMEA: Year-over-year growth
Exhibit 18: Top 3 countries in EMEA
Exhibit 19: DNA probe-based diagnostics market in APAC 2016-2021 ($ billions)
Exhibit 20: DNA probe-based diagnostics market in APAC: Year-over-year growth
Exhibit 21: Top 3 countries in APAC
Exhibit 22: Some examples of infectious diseases caused by pathogenic microorganisms
Exhibit 23: Strategic success factors for vendors
Exhibit 24: Investment opportunity mapping
Exhibit 25: Abbott Laboratories: Profile
Exhibit 26: Abbott Laboratories: Strength analysis
Exhibit 27: Abbott Laboratories: Strategy assessment
Exhibit 28: Abbott Laboratories: Opportunity assessment
Exhibit 29: F. Hoffmann-La Roche: Profile
Exhibit 30: F. Hoffmann-La Roche : Strength analysis
Exhibit 31: F. Hoffmann-La Roche strategy assessment
Exhibit 32: F. Hoffmann-La Roche opportunity assessment
Exhibit 33: GE Healthcare: Profile
Exhibit 34: GE Healthcare: Strength analysis
Exhibit 35: GE Healthcare: Strategy assessment
Exhibit 36: GE Healthcare: Opportunity assessment
Exhibit 37: Thermo Fisher Scientific: Profile
Exhibit 38: Thermo Fisher Scientific: Strength analysis
Exhibit 39: Thermo Fisher Scientific: Strategy assessment
Exhibit 40: Thermo Fisher Scientific: Opportunity assessment



【掲載企業】

Abbott Laboratories, F. Hoffmann La Roche, GE Healthcare, Thermo Fisher Scientific, BD, Biogenex, bioMerieux, Biolegio, Luminex, and MP Biomedicals.


【資料のキーワード】

DNAプローブベース診断

★調査レポート[DNAプローブベース診断の世界市場2017-2021] (Global DNA Probe-based Diagnostic Market 2017-2021 / IRTNTR15308)販売に関する免責事項
[DNAプローブベース診断の世界市場2017-2021] (Global DNA Probe-based Diagnostic Market 2017-2021 / IRTNTR15308)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆